Markets:

Overview

News

Currencies

International

Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

6.750 -0.030 (-0.44%)

Official Closing Price Updated: 7:00 PM EDT, Sep 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

23 Stocks That Have Sold Off Hard Since The Russia-Ukraine War Began ↗

March 11, 2022

The S&P 500 is having a rough start to 2022, down 11.27% year to date. Since Russia invaded Ukraine on Feb. 24, the S&P 500 has fallen an additional 0.78%. Following are...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 2, 2022 ↗

March 02, 2022

Upgrades Barclays upgraded the previous rating for Equitrans Midstream Corp (NYSE:ETRN) from Underweight to Equal-Weight. Equitrans Midstream earned $0.07 in the fourth...

Via Benzinga

Why BofA Sees 'Better Entry Point' In Ginkgo Bioworks Stock ↗

January 28, 2022

Ginkgo Bioworks Holdings Inc (NYSE: DNA) is “at the forefront of the rising SynBio wave, a market we think holds much long-term promise,” according to BofA Securities.

Via Benzinga

7 Stocks to Buy After Sentiment Slipped to Lows ↗

February 17, 2022

With sentiment souring over inflation and other concerns, contrarians may have an opportunity to bank on certain stocks to buy like these.

Via InvestorPlace

Did Going Public Give This Company Momentum? Stran & Company Closes First Acquisition; Adds Over $7 Million in Annualized Revenue ↗

February 03, 2022

Photo by Catkin on Pixabay This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Some...

Via Benzinga

Ginkgo Bioworks Announces Acquisition Of Massachusetts COVID-19 Testing Provider Project Beacon COVID-19 LLC; Terms Not Disclosed ↗

January 19, 2022

Acquisition to enable Ginkgo to bolster its growing biosecurity platform and provide expanded COVID-19 testing options to communities in Massachusetts and beyond BOSTON, Jan. 19,...

Via Benzinga

Why Ginkgo Bioworks Shares Are Trading Higher Today ↗

January 12, 2022

Ginkgo Bioworks Holdings Inc (NYSE: DNA) is trading higher Wednesday after the company reported preliminary unaudited 2021 revenue highlights and a business review. Ginkgo...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 07, 2022

Gainers Absci (NASDAQ:ABSI) shares increased by 51.5% to $9.3 during Friday's pre-market session. The market value of their outstanding shares is at $861.1 million....

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022 ↗

January 07, 2022

Upgrades According to Wolfe Research, the prior rating for CVR Energy Inc (NYSE:

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

January 05, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

January 05, 2022

Before 10 am on Wednesday, 99 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: Sea (NYSE:SE) was the largest firm by market cap to set a...

Via Benzinga

Stocks Hitting New 52-Week Lows Today ↗

January 03, 2022

On Monday morning, 60 companies achieved new lows for the year. Points of Interest From Today's 52-Week Lows And Highs: Ginkgo Bioworks Holdings (NYSE:DNA) was...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

December 03, 2021

Gainers Celyad Oncology (NASDAQ:CYAD) stock moved upwards by 32.58% to $4.72 during Friday's regular session. Trading volume for this security as of 12:30 EST is 45.2...

Via Benzinga

41 Stocks Moving In Friday's Mid-Day Session ↗

December 03, 2021

Gainers IO Biotech, Inc. (NASDAQ: IOBT) jumped 42% to $11.74. The company, last month, priced its IPO at $14 per share. Celyad Oncology SA (NASDAQ: CYAD) shares jumped 38.7% to...

Via Benzinga

Topics Initial Public Offering

58 Biggest Movers From Friday ↗

December 06, 2021

Gainers Hagerty, Inc. (NYSE: HGTY) shares jumped 46.5% to close at $15.62. TuanChe Limited (NASDAQ: TC) gained 44.7% to settle at $3.30. IO Biotech, Inc. (NASDAQ: IOBT) shares...

Via Benzinga

48 Biggest Movers From Yesterday ↗

October 21, 2021

Gainers Xiaobai Maimai Inc. (NASDAQ: HX) shares surged 98.4% to settle at $18.87 on Wednesday on above-average volume. The company on Tuesday disclosed the resignation of its CEO...

Via Benzinga

Why Shares of Ginkgo Bioworks Plunged Today ↗

October 20, 2021

A new project in the Lone Star state wasn't enough to convince the bears to hold on to their shares.

Via The Motley Fool

32 Stocks Moving In Wednesday's Mid-Day Session ↗

October 20, 2021

Gainers Sesen Bio, Inc. (NASDAQ: SESN) rose 34.7% to $1.36. The FDA granted Sesen Bio’s request for a Type A meeting to discuss the Chemistry, Manufacturing, and Controls (...

Via Benzinga

Mid-Afternoon Market Update: Dow Surges Over 100 Points; Harmony Biosciences Shares Spike Higher ↗

October 19, 2021

Toward the end of trading Tuesday, the Dow traded up 0.33% to 35,374.03 while the NASDAQ rose 0.54% to 15,103.67. The S&P also rose, gaining 0.55% to 4,511.35. The U.S. has...

Via Benzinga

Topics Stocks

52 Biggest Movers From Yesterday ↗

October 20, 2021

Gainers Xiaobai Maimai Inc. (NASDAQ: HX) shares climbed 42.6% to close at $9.51 on Tuesday. Xiaobai Maimai said Xiaobao An resigned as CEO. Kaival Brands Innovations Group...

Via Benzinga

44 Biggest Movers From Yesterday ↗

October 15, 2021

Gainers Benessere Capital Acquisition Corp. (NASDAQ: BENER) shares jumped 66.5% to close at $0.4530 on Thursday. Grove, Inc. (NASDAQ: GRVI) gained 39.3% to close at $6.98 after...

Via Benzinga

Ginkgo Bioworks Price Predictions: Why One Analyst Thinks Hard-Hit DNA Stock Can Hit $14.50 ↗

October 14, 2021

Today, a bullish analyst price target placed on Ginkgo Bioworks has sent DNA stock on a nice ride as investors pile into this growth play.

Via InvestorPlace

Why Shares of Gingko Bioworks Are Skyrocketing Today ↗

October 14, 2021

Wall Street is waxing bullishly on this synbio start-up.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2021 ↗

October 13, 2021

Upgrades DA Davidson upgraded the previous rating for Columbia Banking System Inc (NASDAQ:

Via Benzinga

Never Mind Ginkgo Bioworks' Drama -- This Synthetic Biology Stock Is Still a Buy ↗

October 13, 2021

If the latest short-seller attack on Ginkgo Bioworks has you nervous about synthetic biology, consider the industry leader.

Via The Motley Fool

DNA Stock: The Bull Call That Has Ginkgo Bioworks Bouncing Back After Last Week’s “Scam” Accusation ↗

October 12, 2021

Ginkgo Bioworks (DNA) stock is doing well on Tuesday as it recovers with new coverage from an analyst with a bull stance.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2021 ↗

October 12, 2021

Upgrades For Callaway Golf Co (NYSE:ELY), Compass ...

Via Benzinga

46 Biggest Movers From Yesterday ↗

October 12, 2021

Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares jumped 93.9% to close at $35.36 on Monday. The FDA removed the full clinical hold on Protagonist Therapeutics’...

Via Benzinga

28 Stocks Moving In Monday's Mid-Day Session ↗

October 11, 2021

Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares surged 85% to $33.78. The FDA removed the full clinical hold on Protagonist Therapeutics’ rusfertide clinical...

Via Benzinga

Cathie Wood's Ark Invest Piles Up Another $15.8M In Gingko On Dip Amid Short-Seller Allegations ↗

October 11, 2021

Cathie Wood-led Ark Invest on Friday snapped up more shares in Ginkgo Bioworks Holdings Inc (NYSE: DNA) on the dip. The popular money manager’s investment firm snapped up 1....

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.